Indian Journal of Critical Care Case Report

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  3 (2024)
Volume  2 (2023)
Volume  1 (2022)
Related articles

VOLUME 3 , ISSUE 5 ( September-October, 2024 ) > List of Articles

CASE REPORT

Imipenem Sensitive Meropenem-resistant Klebsiella: An Unusual Presentation

Amit Goel, Arvind Amar, Binal Gondaliya

Keywords : Antimicrobial resistance, Case report, Extended-spectrum β-lactamase, Imipenem-susceptible meropenem-resistant Klebsiella pneumoniae, Klebsiella pneumoniae

Citation Information : Goel A, Amar A, Gondaliya B. Imipenem Sensitive Meropenem-resistant Klebsiella: An Unusual Presentation. 2024; 3 (5):123-126.

DOI: 10.5005/jp-journals-11006-0125

License: CC BY-NC 4.0

Published Online: 27-08-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: The increasing burden associated with drug-resistant bacteria is a global concern, and this issue has been highlighted across the world in the political arena through the Global Action Plan on antimicrobial resistance (AMR). Antimicrobial agents play a pivotal role and can be groundbreaking if chosen and administered correctly. Case description: Here, we describe a patient diagnosed with bacterial infection with an atypical susceptibility pattern. Conclusion: Imipenem-susceptible meropenem-resistant Klebsiella pneumoniae (ISMRK) is an unusual strain with varying acquired susceptibility. Comprehensive workup, knowledge, and appropriate treatment have been shown to lead to better outcome.

PDF Share
  1. WHO. Global Leaders Group on antimicrobial resistance. 2021.
  2. WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017.
  3. Shigemoto N, Kuwahara R, Kayama S, et al. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Diagn Microbiol Infect Dis 2012;72(1):109–112. DOI: 10.1016/j.diagmicrobio.2011.09.019
  4. Kouda S, Ohara M, Onodera M, et al. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J Antimicrob Chemother 2009;64(1):46–51. DOI: 10.1093/jac/dkp142
  5. Barenfanger J, Drake C, Karich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999;37(5):1415–1418. DOI: 10.1128/JCM.37.5.1415-1418.1999
  6. Harino T, Kayama S, Kuwahara R, et al. Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems. J Clin Microbiol 2013;51(8):2735–2738. DOI: 10.1128/JCM.02649-12
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.